1. Switzerland Stocks

  2. •

    Health technology

  3. •

    Medical specialties
COLTENE Holding AG

COLTENE Holding AG

49.00
CHF
+0.25
(+0.51%)
305.94MMarket Cap
Mar 05Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
37.95
38.48
36.64
38.11
39.83
43.27
45.83
41.56
46.74
44.71
40.62
41.87
40.18
- -
Basic EPS, GAAP
3.13
3.71
3.16
4.1
4.52
3.61
3.35
1.38
5.31
4.35
2
3.43
2.5
- -
Free Cash Flow per Basic Share
4.02
3.87
3.24
4.02
4.15
2.47
1.76
4.24
3.78
2.53
2.89
3.82
1.29
- -
Dividend per Share
1.8
2.2
2.5
2.2
2.7
2.68
3
1.5
3
3.3
3.3
2
2.5
- -
Book Value per Share
23.15
24.68
24.11
26.63
28.85
14.77
15.27
15.1
17.97
18.78
16.21
18.21
16.82
15.58
Tangible Book Value per Share
12.27
13.87
14.42
16.77
18.61
14.45
14.87
14.5
17.15
17.73
15.15
17.23
15.72
14.54
Basic Weighted Avg Shares
4
4
4
4
4
5
6
6
6
6
6
6
6
6
Sales/Revenue/Turnover
160
162
154
161
168
204
274
248
279
267
243
250
240
- -
Operating Margin (%)
12.15
13.74
13.2
14.81
15.17
12.44
11.69
12.93
15.68
13.07
8.08
10.73
8.75
- -
Depreciation Expense
5
5
5
6
6
6
6
11
6
7
7
7
7
- -
Net Income, GAAP
13
16
13
17
19
17
20
8
32
26
12
20
15
- -
Effective Tax Rate (%)
22.43
25.06
25.52
26.34
22.24
26.63
28.82
54.34
23.04
21.06
25.88
22.71
18.99
- -
Profit Margin (%)
8.24
9.63
8.63
10.75
11.35
8.34
7.32
3.31
11.36
9.73
4.92
8.18
6.23
- -
Working Capital
34
44
47
57
63
51
45
45
57
60
44
53
49
43
LT Debt
- -
- -
- -
- -
- -
5
1
- -
- -
- -
- -
- -
- -
- -
Total Equity
98
104
102
112
122
88
91
90
107
112
97
109
101
93
Return on Invested Capital (%)
12.85
13.84
12.43
14.05
15.25
13.51
15.45
6.92
22.09
17.42
9.32
13.74
10.93
- -
Return on Capital (%)
11.95
13.66
11.45
14.57
15.12
12.91
14.23
5.7
21.29
16.92
8.35
14.54
10.36
- -
Return on Common Equity (%)
13.82
15.5
12.97
16.15
16.29
16.2
22.33
9.07
32.09
23.68
11.43
19.9
14.28
- -

Capital Structure

CHF

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
ST Debt
- -
47
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
6
6
6
Market Capitalization
405
321
306

Working Capital

CHF

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
Total Current Assets
120
127
133
Cash, Cash Equivalents & STI
16
21
27
Accounts Receivable, Net
35
42
43
Inventories
63
56
54
Total Current Liabilities
82
77
90
Payables & Accruals
- -
- -
- -
ST Debt
- -
47
- -
Deferred Revenue
- -
- -
- -

Growth Rates

CHF

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
0.83%
2.91%
-7.59%
Free Cash Flow
6.18%
-12.76%
-66.29%
Net Income, GAAP
24.54%
51.49%
-26.99%
Sales/Revenue/Turnover
5.29%
-0.4%
-4.04%
Total Cash Common Dividend
10.9%
19.1%
24.96%

Semi-annual Revenue

CHF

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
250
2025
- -
- -
240
2026
- -
- -
- -

Semi-annual Earnings Per Share

CHF

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
3.43
2025
- -
- -
2.5
2026
- -
- -
- -

Semi-annual Dividends Per Share

CHF

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
2
2025
- -
- -
2.5
2026
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Dominik Arnold
Full Time Employees
1,180
Sector
Health technology
Industry
Medical specialties
Address
Feldwiesenstrasse 20 Altstätten Switzerland 9450
IPO Date
Jun 23, 2006
Website
coltene.com
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
COLTENE Holding AG develops, manufactures and sells consumables, disposables, tools and small equipment for dentists and dental laboratories worldwide. The company offers a comprehensive product portfolio spanning six key segments including endodontics with root canal files, rinsing solutions, obturation systems and post systems; restorative dentistry encompassing temporary and permanent filling materials, adhesive systems and polymerization lamps; prosthetics featuring condensation and addition cross-linking impression materials; treatment auxiliaries such as aspirator tips, dental dams, wound care and cotton wool products; infection control with thermal disinfectors, washers, cleaning and disinfecting wipes and autoclaves; and rotating instruments including high-performance rotary tools and diamond burs like ALPEN. Subsidiaries and brands include SciCan for hygiene products, MicroMega for endodontic instruments, KENDA for dental silicone polishers, Diatech for cutting instruments and CEI. COLTENE Holding AG, founded in 2005 and headquartered in Altstätten, Switzerland, operates production facilities in the USA, Canada, Germany, France, Hungary and Switzerland, with sales organizations across Europe, the Middle East, Africa, North America, Latin America, Asia and Oceania targeting dentists, dental service organizations, clinics and laboratories. In recent developments, the company reports strong financial growth for 2024 with net sales up 3.1% to CHF 250.3 million and an improved EBIT margin of 10.6%, driven by economies of scale, cost controls and its Operational Excellence strategy including a global procurement organization; launches new innovations at IDS 2025 such as HySolate Liquid Dam for gingiva protection, Kenda ShapeGuard polishing system, MicroMega One Glider and RECI Glider endodontic files, RoeKo Gelatamp hemostatic gels and BRILLIANT Lumina hydrogen peroxide-free whitening; introduces the HYDRIM 112W washer-disinfector in North America to reduce manual labor and costs by up to 60%; and appoints Matthias Altendorf as new Chairman of the Board following the 2025 Annual General Meeting.